On-Demand Catalog

All sessions average between 60 and 90 minutes.

Food For Thought: Functional Foods and Nutrition-Based Communication
FDA’s Legal Authority Over Laboratory Developed Tests
Compounding Drug Products Due to Supply Chain Access in Light of COVID-19
FDA’s Compounding Memorandum of Understanding with States: Questions, Concerns, and What’s Next
Continued Reliance on Foreign Drug Manufacturing and the Drug Supply Chain: Manageable Risk or Public Health Concern?
Tobacco-Free Nicotine Products: Evolution, Research, and Remaining Concerns
Reviewing FDA’s Recently Released New Era of Smarter Food Safety Blueprint
Modified Risk Tobacco Products (MRTPs): Navigating the MRTP Process, Post-Order Marketing, and Assessing Whether it is an Effective Tool for Risk Communication
State of FDA Medical Product Manufacturer Inspections During and After COVID-19
Premarket Tobacco Product Applications (PMTAs) and the Impending Deadline

Filter Results